Lessons from human teratomas to guide development of safe stem cell therapies.
about
Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An OverviewLivestock models for exploiting the promise of pluripotent stem cellsDirect optical activation of skeletal muscle fibres efficiently controls muscle contraction and attenuates denervation atrophyUnprecedented cell-selection using ultra-quick freezing combined with aquaporin expressionProgressing a human embryonic stem-cell-based regenerative medicine therapy towards the clinicIntegrated Genomic Analysis of Diverse Induced Pluripotent Stem Cells from the Progenitor Cell Biology ConsortiumEmployment of the Triple Helix concept for development of regenerative medicine applications based on human pluripotent stem cellsEngraftment of human iPS cells and allogeneic porcine cells into pigs with inactivated RAG2 and accompanying severe combined immunodeficiency.Path to the clinic: assessment of iPSC-based cell therapies in vivo in a nonhuman primate model.Transplanted terminally differentiated induced pluripotent stem cells are accepted by immune mechanisms similar to self-tolerance.Increased activity of TNAP compensates for reduced adenosine production and promotes ectopic calcification in the genetic disease ACDC.A mystery unraveled: nontumorigenic pluripotent stem cells in human adult tissuesLow energy shock wave therapy induces angiogenesis in acute hind-limb ischemia via VEGF receptor 2 phosphorylation.Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.Generation and homing of iPSC-derived hematopoietic cells in vivoTime to reconsider stem cell induction strategiesStem cells: the pursuit of genomic stability.Human corneal epithelial subpopulations: oxygen dependent ex vivo expansion and transcriptional profiling.Concise review: workshop review: understanding and assessing the risks of stem cell-based therapiesBioengineered stem cells as an alternative for islet cell transplantation.A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking.Hurdles to clinical translation of human induced pluripotent stem cellsShock wave treatment after hindlimb ischaemia results in increased perfusion and M2 macrophage presence.Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.Challenging Regeneration to Transform Medicine.Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues.Comparison of Magnetic Resonance Imaging and Serum Biomarkers for Detection of Human Pluripotent Stem Cell-Derived TeratomasSTB-HO, a novel mica fine particle, inhibits the teratoma-forming ability of human embryonic stem cells after in vivo transplantation.Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.Shock Wave Treatment Protects From Neuronal Degeneration via a Toll-Like Receptor 3 Dependent Mechanism: Implications of a First-Ever Causal Treatment for Ischemic Spinal Cord Injury.Immunogenicity and functional evaluation of iPSC-derived organs for transplantationLinks between DNA Replication, Stem Cells and Cancer.Totipotency: what it is and what it is notMultiplexing SERS nanotags for the imaging of differentiated mouse embryonic stem cells (mESC) and detection of teratoma in vivo.Mechanisms Regulating Stemness and Differentiation in Embryonal Carcinoma Cells.Introduction to stem cells and regenerative medicine.Genetic strategies to investigate neuronal circuit properties using stem cell-derived neurons.Limbal side population cells: a future treatment for limbal stem cell deficiency.The non-coding road towards cardiac regeneration.
P2860
Q26770087-DCA4DA15-3915-4E83-BB51-EC89364B9C16Q27011082-1BCDDB2A-7BFC-4F1C-9231-41849C800EFBQ27321734-512DD34E-1890-4A6D-890E-205072405D95Q27324336-07F87218-6502-4542-9999-A4C268CDD8F7Q28080911-1C65805A-1F53-4C95-B074-1C47B5B41001Q28596287-DB79B624-12A5-45EC-8747-395368779AB6Q33600798-A730E9C0-24E0-4E08-B78F-4EC853147507Q33665719-A0387A06-D10D-44A3-A9F1-785301FC71ACQ33760206-913B5A0B-21EA-4EC5-A99A-5C8CBBEB4CB2Q33822831-6092E550-3E95-43D5-B6D1-F413E0FE6A1FQ33848594-FA33DE1A-F400-407B-A7F2-2D006171FC49Q33911166-D2287F34-9D15-4D34-AB92-8245188EF65CQ34004811-1DABE96A-F3B4-4528-BDE6-6F7ADA780BADQ34041000-5036B37D-2EC4-4541-931A-91CA0029CB68Q34232257-DACEE2B2-B3C8-4799-B614-DEB727E0C42FQ34354372-CFD42860-52BC-4E1D-BB08-3E804EBB28A7Q34414126-07A4138F-ED2D-4F77-8B70-F0BA067835AAQ34685564-70040869-1A5B-4071-A265-1E39A6F626CBQ34754361-ED996F33-8035-420F-838A-ECA511A1FBFCQ35200156-105A0691-B5AF-4CC5-BB57-76F022EF5BD9Q35210721-A855BCB1-AB05-49DB-9B48-3CF9FF98C74FQ35407728-E521946A-EEEC-46E6-BABD-2DD17171435CQ36040255-31AB4BFF-3048-433E-85B4-A096384B74D7Q36149685-E35D073C-7D1E-47A7-825C-6C40174A8824Q36379371-B41881ED-5F67-4B01-9DBB-5CFD14B5E402Q36440774-A0C485BE-A5CF-45B3-AC12-8ED42B3CA6A2Q36531665-2D105ADF-5934-4EAB-AB00-44E96F14C552Q36569941-78A4E200-9F76-4BC6-A2D5-9417DCDEDCBCQ36771914-438B6BDA-9622-4197-AC42-8EA5319E53FFQ36808550-70CB0AAF-FC6F-4DD7-92C2-E39A85184702Q36836022-6B1B1E12-8679-489E-99F9-5DFB2B67B8BFQ36882692-0CE1E243-4BEC-43CE-B60C-B69CC907FEBCQ37676222-60CBF9CF-67ED-44DB-B387-D88B6C3FEC76Q37710687-AFEDFE48-7FBD-47CA-9DB7-23C76453E2C3Q37711057-480E34C3-CC7A-4CF0-BC18-0A3AFC1F5FBCQ37714726-1666AED5-BEFE-43D1-B8A1-853833B76251Q38069041-70E8CDF8-133E-43CD-812F-2ABB025C40AEQ38069573-FD946560-41D2-41E0-B6D1-745BEDFFD3E3Q38102770-8678D38A-3672-439D-B484-79F3EBBC5344Q38116760-EB579A75-3964-4FFB-8EDE-98C972587150
P2860
Lessons from human teratomas to guide development of safe stem cell therapies.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Lessons from human teratomas to guide development of safe stem cell therapies.
@ast
Lessons from human teratomas to guide development of safe stem cell therapies.
@en
Lessons from human teratomas to guide development of safe stem cell therapies.
@nl
type
label
Lessons from human teratomas to guide development of safe stem cell therapies.
@ast
Lessons from human teratomas to guide development of safe stem cell therapies.
@en
Lessons from human teratomas to guide development of safe stem cell therapies.
@nl
prefLabel
Lessons from human teratomas to guide development of safe stem cell therapies.
@ast
Lessons from human teratomas to guide development of safe stem cell therapies.
@en
Lessons from human teratomas to guide development of safe stem cell therapies.
@nl
P2860
P356
P1433
P1476
Lessons from human teratomas to guide development of safe stem cell therapies
@en
P2093
Justine J Cunningham
Thomas M Ulbright
P2860
P2888
P304
P356
10.1038/NBT.2329
P577
2012-09-01T00:00:00Z